Paul Carney, MD.
Co-Founder, Scientific & Medical Advisor
Nationally recognized clinician-scientist/epilepsy expert. Over $25M in federal funding (NIH, NSF, DOD). Board-certified pediatric neurologist. Over 400 peer-review papers, patients, and other works on epilepsy drug and device discovery. 10 U.S. patents and has authored several peer-reviewed publications, books and book chapters in epilepsy with a primary focus on novel drug discovery, biomarkers, and nanotechnology and gene therapy.